Sussman Norman 4
4 · DURECT CORP · Filed Nov 4, 2020
Insider Transaction Report
Form 4
DURECT CORPDRRX
Sussman Norman
Chief Medical Officer
Transactions
- Award
Stock Option
2020-11-02+200,000→ 200,000 totalExercise: $1.77Exp: 2030-11-02→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]25% of the total number of shares subject to the option will vest and become exercisable on November 2, 2021, and 1/16th of the total number of shares subject to the option will vest and become exercisable at the end of each three-month period thereafter, subject to the continuous service of the Reporting Person on each vesting date.